Piperidine

Piperidine

SCHEMBL6518941

C1CCNCC1.O=C(O)SSc1ccccc1

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HPGD P15428 3/20 0.38
MAPT P10636 1/20 0.38
MGLL Q99685 1/20 0.38
SIGMAR1 Q99720 1/20 0.36
NPC1 O15118 4/20 0.33
RAB9A P51151 4/20 0.33
KMT2A Q03164 2/20 0.33
FFAR1 O14842 1/20 0.33
ALDH1A1 P00352 4/20 0.33
HTR1A P08908 2/20 0.33
HTR3A P46098 2/20 0.33
POLB P06746 1/20 0.33
USP2 O75604 1/20 0.33
TSHR P16473 1/20 0.33
HTR2C P28335 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3766616 0.82 HPGD (0.55) HSD17B10SMN1; SMN2HPGDMAPTMGLL
Phthalic Acid SCHEMBL5875074 0.71 ALDH1A1 (0.61) HSD17B10SMN1; SMN2HPGDMAPTSIGMAR1
Benzoic Acid SCHEMBL1716154 0.71 TSHR (0.61) HSD17B10SMN1; SMN2HPGDSIGMAR1NPC1
Benzoic Acid SCHEMBL1249244 0.71 TSHR (0.61) HSD17B10SMN1; SMN2HPGDSIGMAR1NPC1
Benzophenone SCHEMBL3444030 0.71 ALDH1A1 (0.61) HSD17B10SMN1; SMN2HPGDMAPTSIGMAR1
Phthalic Acid SCHEMBL5875064 0.71 ALDH1A1 (0.61) HSD17B10SMN1; SMN2HPGDMAPTSIGMAR1
Benzoic Acid SCHEMBL1088757 0.69 TSHR (0.58) HSD17B10SMN1; SMN2HPGDSIGMAR1NPC1
Benzoic Acid SCHEMBL2492854 0.69 TSHR (0.64) HSD17B10SIGMAR1KMT2AALDH1A1USP2
Phenylacetic Acid SCHEMBL9555521 0.68 AKR1B1 (0.68) HPGDKMT2AFFAR1ALDH1A1POLB
Benzamide SCHEMBL694831 0.68 TSHR (0.64) HSD17B10SMN1; SMN2HPGDMAPTSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050008568-A1 Technetium or rhenium complexes, radiopharmaceutical products comprising them SCHERING AKTIENGESELLSCHAFT (DE) 2005-01-13 US disclosed
EP-1453841-A1 TECHNETIUM OR RHENIUM COMPLEXES, RADIOPHARMACEUTICAL PRODUCTS COMPRISING THEM SCHERING AKTIENGESELLSCHAFT (DE) 2004-09-08 EP disclosed
WO-2003044031-A1 TECHNETIUM OR RHENIUM COMPLEXES, RADIOPHARMACEUTICAL PRODUCTS COMPRISING THEM SCHERING AKTIENGESELLSCHAFT (DE) 2003-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050008568-A1 Technetium or rhenium complexes, radiopharmaceutical products comprising them TSHR, MRPS35, TFRC HSD17B10 2522/4885SMN1; SMN2 4861/4885HPGD 4653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.